LAM PHARMA 631629 NEWS 13.2. - 500 Beiträge pro Seite

[guru2003]

Lam Pharma befindet sich auf Allzeittief bei 22 $-cents.

Gestern positive News:

LAM Pharmaceutical Strengthens Direct Sales Program by Retaining Specialty Sales
Organization Pharm Force

LEWISTON, N.Y., Feb 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- LAM
Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; Frankfurt: LAM; Berlin: LAM), a
biomedical company focused on the development and commercialization of novel
wound healing and transdermal drug delivery systems, announced today it has
retained Pharm Force as a specialty sales force for L.A.M. IPM Wound Gel(TM).
Under the agreement, Pharm Force will promote and sell the L.A.M. IPM Wound
Gel(TM) to wound care centers, podiatrists, dermatologists, skilled nursing
centers, home care agencies, durable medical equipment suppliers, hospitals and
pharmacists.

Pharm Force, headquartered in Doylestown, PA, has an established sales force,
experienced in selling both over-the-counter and prescription products to these
markets. Pharm Force will provide sales coverage to nine sales territories in
seven states primarily in the Eastern U.S. LAM Pharmaceutical personnel will
immediately begin training the Pharm Force team on L.A.M. IPM Wound Gel(TM) with
the first sales from the team expected in early March.

"As part of the seven-point marketing strategy outlined to shareholders last
fall, we articulated that we planned on phasing in additional sales
representation in key territories through the next two quarters. We are pleased
to announce that we have taken a major step towards achieving this objective in
partnering with Pharm Force for nine of the most significant sales territories
in the country. Shortly we will be augmenting the Pharm Force team with
additions to our own direct sales team and retaining additional sales
organizations as we build out our sales program," stated Joseph T. Slechta,
President & CEO of LAM Pharmaceutical.

"We researched and evaluated a number of sales organizations and selected Pharm
Force based on the reputation of their sales representatives and the time,
attention and energy they devote to their current product lines. L.A.M. IPM
Wound Gel(TM) will complement their current portfolio by providing a product for
chronic and refractory wounds," commented Rick Brokenshire, Vice President of
Sales & Marketing.

About LAM Pharmaceutical, Corp.

L.A.M. Pharmaceutical, Corp., http://www.lampharm.com, is a biomedical company
with laboratories in Lewiston, New York, and a business office in Toronto. LAM
focuses on the development and commercialization of novel wound healing and
transdermal drug delivery systems that offer patients, among other benefits,
safer and more effective treatment for a variety of serious diseases. The
technology is based on an original L.A.M. Ionic Polymer Matrix(TM) technology
(L.A.M. IPM(TM)), a proprietary and patented combination (a total of 14 U.S.
issued and approved patents) of electrically charged and non-charged molecules
with wound-healing properties. L.A.M. IPM(TM) technology is also appropriate for
use with well-established drugs, allowing for the sustained delivery of greater
amounts to the target areas than is otherwise possible by oral means, thus
prolonging therapeutic activity.

Statements in this press release regarding our business which are not historical
facts are "forward-looking statements" that involve risks and uncertainties
which could cause the Company`s actual results and financial condition to differ
materially from those anticipated by the forward-looking statements. These risks
and uncertainties include, but are not limited to uncertainties relating to the
need for additional funds and corporate partners, product liability, dependence
on third parties for manufacturing and marketing, the early stage of products
being marketed or under development, patent risk and competition.

L.A.M. Ionic Polymer Matrix(TM), L.A.M. IPM(TM) and IPM Wound Gel(TM) are
trademarks of L.A.M. Pharmaceutical, Corp.

L.A.M. IPM Wound Gel(TM) is protected by one or more of the following patents:
5,897,880; 6,120,804; 6,007,843; 6,063,405.

SOURCE LAM Pharmaceutical, Corp.


Wann kommen eigentlich Zahlen?

Guru2003

[ulgo]

Also Guru2003 - ich kann Dich im Thread-Nr.: 649833 nicht finden, also was interessiert Dich LAMP?

[AdhocAnalyst]

Unser neuer "guru2003" postet ständig, dass er nicht Hairman ist. Doch warum schreibt er den identischen Schrott in den identischen Threads?? Die selbe schreibweise, die selben Aktien und die identischen Beiträge!!
Es gibt schon komische Menschen auf dieser Welt